文献速递产科生殖医学

枸橼酸氯米芬的胎儿安全性:一项基于人群的回顾性队列研究

The fetal safety of clomiphene citrate: a population-based retrospective cohort study.
PubMed 文献 · BJOG · 2017-05-15

该研究基于以色列南部1998至2009年四个数据库的114961名孕妇,其中1872名暴露于枸橼酸氯米芬(CC)。暴露定义为受孕前2个月至妊娠第1个月配发CC。未发现CC暴露与总体重大畸形率(aOR 1.08,95%CI 0.88-1.32)或各畸形亚类率相关,无脑畸形(aOR 2.27,95%CI 0.44-11.71)和食管闭锁(aOR 3.681,95%CI 0.65-20.76)亦无关联。

要点

  • CC暴露未增加总体重大畸形风险(aOR 1.08,95%CI 0.88-1.32)。
  • CC暴露与无脑畸形(aOR 2.27,95%CI 0.44-11.71)无关联。
  • CC暴露与食管闭锁(aOR 3.681,95%CI 0.65-20.76)无关联。

核心结论

  • 在这项大型基于人群的回顾性队列研究中,CC暴露与总体重大畸形率或特定畸形率的风险增加均无关。

研究设计与样本

  • 基于人群的回顾性队列研究,合并用药、出生、住院和终止妊娠四个数据库。
  • 纳入1998至2009年在Soroka医疗中心分娩或终止妊娠的以色列南部所有女性,共114961名孕妇。
  • 暴露定义为受孕前2个月至妊娠第1个月配发CC,共1872名暴露。
  • 采用多因素logistic回归计算调整比值比(aOR),控制母亲年龄、孕前糖尿病、产次、族裔、分娩/终止妊娠日历年、吸烟以及促性腺激素和黄体酮使用。

主要发现

  • CC暴露与总体重大畸形率无关联(aOR 1.08,95%CI 0.88-1.32)。
  • CC暴露与各畸形亚类率均无关联。
  • CC暴露与无脑畸形无关联(aOR 2.27,95%CI 0.44-11.71)。
  • CC暴露与食管闭锁无关联(aOR 3.681,95%CI 0.65-20.76)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether exposure to clomiphene citrate (CC) for ovulation induction is associated with major malformations overall or with specific fetal anomalies. DESIGN: We conducted a population-based retrospective cohort study. Exposure was defined as CC dispension from 2 months before conception through the first month of pregnancy. SETTINGS: Four databases were combined: medication, birth, hospitalization, and terminations of pregnancy. POPULATION: The study included all women in southern Israel who gave birth or underwent termination of pregnancy at Soroka Medical Center, from 1998 to 2009. METHODS: The rates of major malformations overall and six different subcategories of anomalies were evaluated. The crude odds ratio (OR) was calculated with a 95% confidence interval (95% CI). Subsequently the adjusted odds ratio (aOR) was calculated using multiple logistic regression models controlling for maternal age, pre-pregnancy diabetes, parity, ethnicity, the calendar year in which the birth/termination of pregnancy took place, smoking, and the use of gonadotropins and progesterone. MAIN OUTCOME MEASURES: Major malformations overall and specific fetal malformations by organ systems. RESULTS: Of 114 961 pregnant women, 1872 were exposed to CC. No association was detected between exposure to CC and rates of major malformations overall (aOR 1.08, 95% CI 0.88-1.32) or rates of subcategories of malformations. Exposure was not associated with anencephaly (aOR 2.27, 95% CI 0.44-11.71) or oesophageal atresia (aOR 3.681, 95% CI, 0.65-20.76). CONCLUSIONS: In this large population-based retrospective cohort study, exposure to CC was not associated with an increased risk of either rates of major malformations overall or rates of specific malformations. TWEETABLE ABSTRACT: An observational study: no increased risk for fetal malformations following exposure to clomiphene citrate.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Weller A, Daniel S, Koren G, et al. The fetal safety of clomiphene citrate: a population-based retrospective cohort study. BJOG. 2017. PMID: 28334503. doi:10.1111/1471-0528.14651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。